Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether the OculusGen Collagen Matrix are effective and safe to implant as an aid of glaucoma surgery.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pro Top & Mediking Company Limited
NCT07244276 · Primary Pterygium
NCT05456425 · Pterygium
NCT07458126 · Recurrent Pterygium, Conjunctival Scarring
NCT06734663 · Pterygium of Conjunctiva and Cornea, Pterygium of Both Eyes, and more
NCT05362253 · Recurrent Pterygium, Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation
Zhongshan Hospital Fudan University
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions